Literature DB >> 6299079

Hypotensive activity of PAF-acether in rats.

C G Caillard, S Mondot, J L Zundel, L Julou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6299079     DOI： 10.1007/bf01965093

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  15 in total

1.  Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.

Authors:  D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Mol Pharmacol       Date:  1977-05       Impact factor: 4.436

2.  A pithed rat preparation suitable for assaying pressor substances.

Authors:  R E SHIPLEY; J H TILDEN
Journal:  Proc Soc Exp Biol Med       Date:  1947-04

3.  Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptors.

Authors:  G M Drew
Journal:  Eur J Pharmacol       Date:  1976-04       Impact factor: 4.432

4.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

5.  [3H]Para-amino-clonidine: a novel ligand which binds with high affinity to alpha-adrenergic receptors.

Authors:  B R Rouot; S H Snyder
Journal:  Life Sci       Date:  1979-08-27       Impact factor: 5.037

Review 6.  Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture.

Authors:  E E Muirhead
Journal:  Hypertension       Date:  1980 Jul-Aug       Impact factor: 10.190

7.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Platelet-activating factor.

Authors:  N J Cusack
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

10.  Platelet activating factor (PAF-acether): total synthesis of 1-O-octadecyl 2-O-acetyl sn-glycero-3-phosphoryl choline.

Authors:  J J Godfroid; F Heymans; E Michel; C Redeuilh; E Steiner; J Benveniste
Journal:  FEBS Lett       Date:  1980-07-28       Impact factor: 4.124
View more
  10 in total

1.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

Authors:  S W Chang; C O Feddersen; P M Henson; N F Voelkel
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

2.  Pathophysiological mechanisms of sudden death induced by platelet activating factor.

Authors:  A M Lefer; H F Müller; J B Smith
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

3.  Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.

Authors:  J R Fletcher; A G DiSimone; M A Earnest
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

4.  Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.

Authors:  M G Sirois; W T de Lima; A J de Brum Fernandes; R J Johnson; G E Plante; P Sirois
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Action of the racemate and the isomers of the platelet-activating factor antagonist bepafant (WEB 2170) after oral administration to guinea-pigs and rats.

Authors:  H O Heuer; B Keller; K Urich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

6.  Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.

Authors:  M Criscuoli; A Subissi
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

7.  Inhibition of prostaglandin G/H synthase unveils a potent effect of platelet activating factor on the permeability of bovine aortic endothelial cells to albumin.

Authors:  Pierre J Farmer; Daphné Girardot; Andrée Lepage; Domenico Regoli; Pierre Sirois
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

8.  Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function).

Authors:  B Jenei; G Lázár; K Bartha; G A Medgyesi
Journal:  Agents Actions       Date:  1991-03

9.  Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.

Authors:  G Camussi; F Bussolino; G Salvidio; C Baglioni
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Characterization of the Phospholipid Platelet-Activating Factor As a Mediator of Inflammation in Chickens.

Authors:  Damien Garrido; Nathalie K Chanteloup; Angélina Trotereau; Adrien Lion; Geoffrey Bailleul; Evelyne Esnault; Sascha Trapp; Pascale Quéré; Catherine Schouler; Rodrigo Guabiraba
Journal:  Front Vet Sci       Date:  2017-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.